DRUG Bright Minds Biosciences Inc.
$73.26▼ -1.84%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$718.83M
P/E Ratio
–
Div Yield
–%
52W Range
31.98 - 123.75
% vs 50 MA
-0.18%
% vs 200 MA
-4.77%
RSI-14
49.4
MACD Histogram
-0.1800
Beta (1Y vs SPY)
1.86
Gross Rev
$0
Gross Profit
$0
EBITDA
–
COGS
$0
Operating Exp
$0
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Jun 2026 (Quarterly)
Social Sentiment
Avg +0.28 · 361 posts
NewsDiscussionGamble?
r/wallstreetbets · Jul 8, 2026
The mention of being 'number 1' in psych drug treatment and needing the last approval is encouraging for DRUG.
positive
+0.50
NewsThis might go to the moon
r/options · Jul 1, 2026
The discussion focuses on the company’s approach to developing drugs – a clear positive indicator given the context.
positive
+0.60
DiscussionYou can take her from my cold, dead hands
r/wallstreetbets · Jun 28, 2026
Combined with the statement about not being able to afford drug money, this indicates a strong negative sentiment toward the company.
very_negative
-0.80
NewsDiscussionWhat do we think about "Mushroom stocks" ?
r/wallstreetbets · Jun 15, 2026
Discussion about a specific sector ('psychedelic stocks') including the company DRUG.
positive
+0.50
NewsDiscussionEli Lilly is ready to soar with their latest results get ready for Triple Action GLP's
r/stocks · Jun 6, 2026
The post highlights the promising clinical results of Eli Lilly's drug candidates, indicating positive future potential.
positive
+0.60
Page 1 of 73 (361 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.